The combination of a poly‐caprolactone/nano‐hydroxyapatite honeycomb scaffold and mesenchymal stem cells promotes bone regeneration in rat calvarial defects. (15th September 2020)

• Record Type: Journal Article
• Authors: Naudot, Marie; Garcia Garcia, Alejandro; Jankovsky, Nicolas; Barre, Anaïs; Zabijak, Luciane; Azdad, Soufiane Zakaria; Collet, Louison; Bedoui, Fahmi; Hébraud, Anne; Schlatter, Guy; Devauchelle, Bernard; Marolleau, Jean‐Pierre; Legallais, Cécile; Le Ricousse, Sophie
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 14:Number 11(2020)
• Page Start: 1570
• Page End: 1580
• Publication Date: 2020-09-15
• Subjects: biomaterials -- bone regeneration -- calvarial defect -- electrospinning -- honeycomb -- mesenchymal stem cell; Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.3114
• Languages: English
• ISSNs: 1932-6254

Abstract

Abstract: Bone tissue engineering goes beyond the limitations of conventional methods of treating bone loss, such as autograft‐induced morbidity and a lack of integration for large grafts. Novel biomimicry approaches (using three‐dimensional [3D] electrospinning and printing techniques) have been designed to offer the most appropriate environment for cells and thus promote bone regeneration. In the present study, we assessed the bone regeneration properties of a composite 3D honeycomb structure from the electrostatic template‐assisted deposition process by an alternate deposition of electrospun polycaprolactone (PCL) nanofibers and electrosprayed hydroxyapatite nanoparticles (nHA) on a honeycomb micropatterned substrate. We first confirmed the cytocompatibility of this honeycomb PCL‐nHA scaffold in culture with bone marrow‐derived mesenchymal stem cells (BM‐MSCs). The scaffold was then implanted (alone or with seeded MSCs) for 2 months in a rat critical‐sized calvarial defect model. The observation of new bone synthesis in situ (monitored using microcomputed tomography every 2 weeks and a histological assessment upon extraction) demonstrated that the honeycomb PCL‐nHA scaffold was osteoconductive. Moreover, the combination of the scaffold with BM‐MSCs was associated with significantly greater bone volume and mineralized regeneration during the 2‐month experiment. The combination of the biomimetic honeycomb PCL‐nHA scaffold with patient mesenchymal stem cells might therefore have great potential for clinical applications and specifically in maxillofacial surgery.